DEA Delays MMJ Cannabis Research While Allowing Texas Ibogaine Studies Without Obstruction: The Tale of Two Schedule I Substances
Two Schedule I drugs. Two research tracks. One DEA double standard.
MMJ BioPharma Cultivation's FDA sanctioned cannabis research has been stonewalled for seven years. Meanwhile, Texas launches state-funded ibogaine trials with full political support and zero DEA obstruction.
Is federal drug policy about science or selective enforcement?
WASHINGTON, DC / ACCESS Newswire / June 15, 2025 / The Drug Enforcement Administration (DEA) has spent the last seven years obstructing MMJ BioPharma Cultivation's federally lawful efforts to research cannabis derived medicine for devastating neurological diseases. Yet this week, the same Drug Enforcement Administration sits idly by as Texas Governor Greg Abbott signs SB 2308, a bold new law investing $50 million into clinical research of ibogaine, a Schedule I psychedelic with no FDA approval and known cardiotoxicity risks.
The DEA hypocrisy is staggering.
Two Schedule I Drugs, Two Opposite Realities
Ibogaine and marijuana are both Schedule I substances - the most restrictive classification under the Controlled Substances Act. This means the DEA claims they have:
And yet, while Texas is encouraged to pursue ibogaine trials through gifts, grants, and state matching funds, MMJ BioPharma has been trapped in a Kafkaesque limbo for attempting the same with cannabis-despite MMJ's direct alignment with the FDA's Investigational New Drug (IND) process, orphan drug designation, and a DEA-compliant manufacturing facility.
'Why is Texas allowed to bypass federal enforcement for psychedelic research while MMJ BioPharma Cultivation is targeted and delayed for developing cannabis-based therapies through the FDA?' stated Duane Boise CEO MMJ.
The Texas Psychedelic Loophole: DEA Selective Enforcement?
Under SB 2308, Texas will now:
There has been no indication that the DEA intends to interfere with this psychedelic research initiative. In fact, Texas officials cite DEA coordination as merely a procedural formality.
Compare that to MMJ BioPharma:
Despite this, DEA attorneys - including those under internal ethics investigation - have argued to dismiss MMJ's claims and to keep the company locked out of cannabis-based drug development.
So let's ask the obvious: Will the DEA block Texas next? Or are Schedule I drugs only 'dangerous' when researched by companies the DEA doesn't control?
Veterans Deserve Science, Not Bureaucracy
Both ibogaine and cannabis have shown promise in treating PTSD, opioid dependency, and neurodegenerative diseases, especially among U.S. veterans. But only one path is being respected by federal regulators: the one funded by politics, not science.
'Patients deserve real medicine, not political footballs,' said Duane Boise, CEO of MMJ International Holdings.
The Inconvenient Truth: MMJ Followed the Law - And Paid the Price
The contrast could not be more striking:
If the DEA allows Texas to move forward unimpeded while continuing to obstruct MMJ's FDA-approved research, it will be a glaring admission of regulatory bias, abuse of discretion, and political favoritism.
Congress, the courts, and the public must now ask:
Is the DEA enforcing the law-or weaponizing it?
If the DEA cannot respect the law, then the law must be used to dismantle the DEA.
MMJ is represented by attorney Megan Sheehan.
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ International Holdings
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Watch These Bitcoin Price Levels Amid Volatile Trading After U.S. Strikes Iran
Bitcoin briefly fell below $99,000 on Sunday to its lowest level in more than six weeks as news that the U.S. had struck Iranian nuclear sites caused investors to reassess their appetite for risky assets. After trending sharply higher between early April and late May, the cryptocurrency has consolidated within a descending channel. Investors should watch crucial support levels on Bitcoin's chart around $100,000 and $92,000, while also monitoring resistance levels near $107,000 and $112, (BTCUSD) briefly fell below $99,000 on Sunday as news that the U.S. had struck Iranian nuclear sites caused investors to reassess their appetite for risky assets. The digital currency moved as low as $98,200 on Sunday afternoon, its lowest level since May 8, amid uncertainty about the geopolitical and economic outlook after the U.S. late Saturday entered a conflict between Israel that had intensified over the past week. In recent trading, bitcoin had rebounded to about $101,200 but was still well down from its high last Monday of near $109,000. Below, we take a closer look at bitcoin's chart and apply technical analysis to identify crucial price levels worth watching out for. After trending sharply higher between early April and late May, bitcoin has consolidated within a descending channel. Over the past week, the cryptocurrency's price has retraced toward the pattern's lower trendline, an area on the chart that closely aligns with the psychological $100,000 level. Moreover, recent selling has coincided with the relative strength index falling below its neutral threshold, signaling weakening price momentum. Let's identify crucial support and resistance levels on Bitcoin's chart. Investors should initially monitor the $100,000 level. This area on the chart is likely to gain significant attention near the descending channel's lower trendline and a range of corresponding trading activity stretching back to last November. A decisive close below this level could see the cryptocurrency's price revisit lower support around $92,000. Investors may seek buying opportunities in this area near a horizontal line that links a series of price action on the chart between November and April. The first resistance level to watch sits around $107,000. The cryptocurrency could face overhead selling pressure in this location near the descending channel's top trendline, which also closely aligns with prominent peaks that formed on the chart in December and January. Finally, buying above this level could see BTC bulls push the price toward $112,000. Investors who have accumulated bitcoin during its recent retracement could decide to lock in profits near last month's high, which also marks the cryptocurrency's all-time high. The comments, opinions, and analyses expressed on Investopedia are for informational purposes only. Read our warranty and liability disclaimer for more info. As of the date this article was written, the author does not own any of the above securities. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CBS News
33 minutes ago
- CBS News
Boston protesters condemn U.S. attack in Iran as Rep. Lynch criticizes president's decision
A crowd of approximately 500 demonstrators took to the streets of downtown Boston Sunday to protest recent U.S. military strikes against Iran, while Gov. Maura Healey was briefed by Homeland Security. The march began at Park Street Station and culminated with a rally on the Boston Common, where activists, community leaders and concerned citizens gathered to make their voices heard. Protesters' demands The demonstration was organized by several advocacy groups, including the National Iranian American Council, Massachusetts Peace Action, Northshore for Palestine, and Jewish Voice for Peace Boston. Protesters said they were calling for a clear rejection by Congress of any steps toward war with Iran, a negotiated nuclear deal, and a formal congressional investigation into the strikes recently ordered by President Donald Trump against Iranian nuclear facilities. Lynch: Congress not told of strikes In an interview with WBZ-TV, Democratic Rep. Stephen Lynch said that Congress was not made aware of these military strikes. "We had no prior contact or notification from the president," said Rep. Lynch. "He informed some of the Republican members and then did not inform the Democratic members. That's a complete breach of protocol. I think every American president in our history has always made sure that when we go into battle, we go in together as one country." Lynch also said that this is something he would consider an act of war, one that would require congressional approval. "It involved the deployment of U.S. forces, and we could have just as easily had casualties there," Rep. Lynch said. Rep. Lynch said that confidential security briefings will be held for members of congress over the coming days. He also added that conversation amongst Republican members of the house are split at the moment, with several members feeling betrayed after President Trump campaigned on not bringing the United States into foreign conflict. "The narrative was that President Trump was going to keep us out of these types of situations," he said. "There will be consequences to these attacks." Healey briefed by Homeland Security In a statement, Massachusetts Gov. Healey said she received a briefing from Department of Homeland Security Secretary Kristi Noem Sunday afternoon. "While there are no specific threats to Massachusetts at this time, we are continuing to coordinate with state, local and federal partners to closely monitor the situation," said Healey in the statement.
Washington Post
33 minutes ago
- Washington Post
Storm's Nneka Ogwumike, WNBA players union president, speaks out on CBA negotiations
SEATTLE — As president of the WNBA's players union, Seattle Storm forward Nneka Ogwumike has been asked time and again about the league's collective bargaining agreement discussions. The WNBA is bringing in more money than ever from sponsors and ticket sales, and will bring in much more from its 11-year media rights deal , worth around $200 million per year starting in 2026 — yet player salaries haven't increased drastically in recent years. In light of other players around the WNBA speaking out, Ogwumike addressed the matter of player salaries following the Storm's 89-79 win over the New York Liberty on Sunday .
